|Articles|February 11, 2009
Lucentis vs PDT: which is more cost-effective?
Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration
Advertisement
Please click
Newsletter
Advertisement
Latest CME
Advertisement
Advertisement











































